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Abstract
Background: Brain reserve, i.e., the ability of the brain to tolerate age- and disease-related changes in a way that
cognitive function is still maintained, is assumed to be based on the lifelong training of various abilities. The
Motivational Reserve in Alzheimer’s (MoReA) is a longitudinal study that aims to examine motivational processes as
a protective factor in mild Alzheimer’s dementia (AD) and mild cognitive impairment (MCI). This paper presents the
results of motivational variables, frequency of diagnoses, and prediction of global cognition as well as depression in
a one-year longitudinal study.
Methods: The sample consists of 64 subjects with MCI and 47 subjects with mild AD at baseline. At baseline, the
physical/neurological examinations, standard clinical assessment, neuropsychological testing, and assessment of
motivational variables were performed. At follow-up (FU) one year later, neuropsychological testing including
cognition, functional abilities, behavioral and affective symptoms, and global clinical assessments of severity have
been repeated.
Results: AD cases have lower motivational capacities as measured with a midlife motivation-related occupational
score and informant-reported present motivational processes, but do not differ with regard to delay of gratification
(DoG) and self-reported motivational processes. DoG and delay discounting (DD) were relatively stable during the
measurement interval. However, 20 % of the MCI cases converted to mild AD at FU, and 17 % of the mild AD cases
converted to moderate AD. The rate of depression of Alzheimer’s disease was 9 at baseline and 21 % at FU, and
the rate of apathy was 7 and 14 %, respectively. Global cognition at FU was mainly predicted by baseline global
cognition but also by one of the motivational variables (scenario test). Depression at FU was predicted mainly by
two motivational variables (self-reported and informant-reported motivational processes).
Conclusions: This research might inform motivation-related strategies for prevention and early intervention with
older people or people at risk for AD.
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Background
One of the goals of current research on ageing and
dementia is to identify the biological and psychological
factors that might help individuals preserve their cognitive
health into old age [1]. Comprehensive reviews identify
several biological (genetic, cardiovascular, and other som-
atic factors) and psychological (cognitive, motivational,
emotional, and social) risk factors for cognitive disorders
in old age [2]. Contemporary, integrative approaches in
cognitive ageing describe an interaction of cognition, mo-
tivation, and emotion [3]. There is in particular a large
body of studies on motivation-cognition interactions com-
ing from neuroscience, social and personality psychology,
and aging research [4].
The present study aims to elucidate the role of motiv-
ational processes in cognitive aging and dementia. In
this introduction, we first define the motivational
processes under investigation; second, we describe the
motivational reserve (MR) model linking motivational
processes to cognitive decline and dementia; and third,
we formulate the goals of the present analysis.
Motivational processes
Motivation is an umbrella term for various processes
involved in goal-directed behaviour [4]. It has been sug-
gested by early personality psychologists [5] and more
differentiated in current models of motivation [6] that
two main motivational phases can be distinguished: goal
setting and goal striving. Goal setting and striving are de-
termined by rather different motivation-related constructs
[7]. While goal setting is determined mainly by control
and expectancy constructs [8] such as self-efficacy [9],
goal striving is rather determined by volitional or self-
regulatory strategies that are needed to cope with difficul-
ties during the implementation phase such as decision
regulation [10], activation regulation [11], and motivation
regulation [10]. Other self-regulatory strategies are also
important during goal striving, e.g., emotion and attention
regulation; however, they are not motivation-related and,
thus, not in focus of this study. Instead, we focus on four
basic motivation-related processes relevant in goal setting
and striving that are usually measured by self-report, and
further variables relating to these four processes, but
measured by behavioural testing, scenario tests, or an
occupation-based scoring procedure.
The four basic motivation-related processes are self-
efficacy (i.e., the belief in being able to master difficult
demands), decision regulation (i.e., the ability to quickly
come to self-congruent decisions), activation regulation
(i.e., the ability to initiate a planned action), and motiv-
ation regulation (i.e., the ability to motivate oneself to
persevere in the face of difficulties). These four constructs
together refer to the motivational processes needed to
effectively implement an intention in a self-regulated
manner, and are relevant in different sub-phases in goal
setting and striving [12]. Decision regulation is needed in
the crossover from goal setting to goal striving; activation
regulation is needed to start with an action; motivation
regulation is needed to keep up with the action or to re-
sume the action. Self-efficacy is important during the all
sub-phases because it determines the amount of self-
regulation effort invested as well as the perseverance.
Our measurement strategy involves different approaches
in addition to self-report measures because self-reports
exhibit a lower accuracy due to lack of awareness in cogni-
tively impaired individuals [13]. All four described motiv-
ational processes are also assessed by informant-ratings as
well as scenario tests. Furthermore, delay of gratification
(DoG) is used which is a behavioural approach to measure
motivational self-regulation [14]. Finally, occupation-
based scoring procedures estimate midlife self-regulatory
processes needed in a certain job [15]. Both, DoG and
occupation-based scoring procedures are assumed to
relate to the four basic motivation-related constructs. The
methods section offers detailed descriptions of these
measurement approaches.
Motivational reserve in Alzheimer’s disease
Studies on the neuropathology of Alzheimer’s disease
(AD) have repeatedly shown that many individuals with
pronounced neuropathological, AD-typical changes in
the brain exhibit no clinical manifestation of dementia
syndrome [16]. One explanation for this finding is the
concept of brain reserve [17–19]. Brain reserve can be
defined as the ability of the brain to tolerate or compen-
sate for age- and disease-related changes in a way that
cognitive function is still maintained. In order to clinically
manifest impairments in the cognitive and functional
abilities of an individual with a larger brain reserve, it is
assumed that the neuropathological damage must be more
severe. The neuropathological processes seem to accumu-
late until they are severe enough to cross a threshold and
be reflected in the clinical picture [18]. Concepts of brain
reserve can explain why people differ in their reserve
capacity. The extension of this threshold of clinical mani-
festation and the increase in brain reserve is one of the po-
tential preventive goals for AD [20].
Theories of brain reserve assume that reserve capacity
depends on a training of several abilities or the exercise of
respective activities throughout life. The consequences of
such a training is a more efficient use of brain networks
and the compensation of affected networks [17]. It has re-
peatedly been demonstrated that activities stimulating the
brain to a sufficient degree during the life course contrib-
ute to an increasing brain reserve. However, the question
of which specific activities fulfill this criterion is not com-
pletely answered so far. Accumulating evidence has been
described for the contributions of motivational, cognitive,
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physical, and social activities. Much research focused on
cognitive activities and used the term cognitive reserve is
[18]. Correspondingly, the authors used the term motiv-
ational reserve (MR) to describe the effect of motivational
activities on reserve capacity [15]. MR can be defined as a
set of motivational abilities or processes that provide the
individual with resilience to neuropathological deterior-
ation [15]. Motivational and cognitive reserve constitute
complementary concepts in our model.
Our model presumes that activating motivational pro-
cesses during the life course rises the number of synaptic
connections and stimulates the development of new
neurons. These neurophysiological alterations increase
the efficacy of usage of relevant brain networks and
enable the brain to compensate for disrupted networks
(this is captured in the term ‘brain reserve’). There is a
wealth of evidence that the human brain still exhibits
plasticity in adult and older life [21]. The brain areas
primarily involved in motivational processes are the
amygdala (fear-motivated behavior), the nucleus accum-
bens (reward-motivated behavior), and the prefrontal
cortex (regulating motivational salience and determining
intensity of responding) [22, 23]. Our model includes
additional factors that might mediate the effect of MR
on further brain areas. These factors act by influencing
stress activation, vascular risk factors, cognitive training,
and emotional health [15, 24].
Several findings suggest that motivational processes
predict cognitive function. A longitudinal study has
shown that occupation-related motivational abilities at
midlife reduce the risk of MCI by 35 % [24]. The effect
on the risk of Alzheimer disease depends on the exist-
ence of an ApoE e4 allele, which was found to intensify
the biochemical disturbances that are characteristic of
AD including beta amyloid deposition, tangle formation,
neuronal cell death, and synaptic plasticity. Midlife
motivational abilities were associated with reduced risk
of AD in ApoE ɛ4 carriers but not in non-carriers [24].
Two other studies support this finding using various
measures of motivation-related concepts. Conscientious-
ness, i.e., the individual’s tendency to control impulses
and be goal directed, was associated with a reduced risk
of AD [25]. Purpose in life, which is associated with
intentionality and goal-directed action that guides
behavior, was related to a reduced risk of MCI and AD
[26]. Furthermore, correlational studies have found that
self-efficacy is associated with academic performance
[27]. Finally, a neuroimaging study has demonstrated
that internal locus of control correlates with hippocam-
pal volume and is thus claimed to be a protective factor
against age-related cognitive decline and hippocampal
atrophy [28].
Cognitive reserve (CR) complements MR in our
model. It has been defined as “the ability to optimize or
maximize performance through differential recruitment of
brain networks, which perhaps reflect the use of alterna-
tive cognitive strategies” ([29], p. 451). Education, occupa-
tion (e.g., manual vs. non-manual, psychosocial demands,
and complexity of work [30], intellectual functioning (IQ
and other cognitive functions) [31], and stimulating cogni-
tive, social, and physical activities [32] are considered to
index CR. Evidence for the CR hypothesis comes from
cross-sectional, case–control, prospective longitudinal,
and functional imaging studies [19, 33]. Prospective stud-
ies show that the risk of developing AD some time later is
increased in less cognitively active adults [34–36].
The clinical implication of the motivational reserve
model is that strategies for enhancing motivational
abilities [37] could be adopted for use in prevention and
treatment programs with older people in general or
people at risk for AD (e.g., MCI). If motivational pro-
cesses add to the prediction of cognitive decline, preven-
tion programs usually including some combination of
cognitive and physical training [32] should be enriched
with motivational training strategies such as adaptive
goal setting and self-motivation [38]. Such motivation-
related interventions might also reduce neuropsychiatric
symptoms of apathy and depression.
Motivation and non-cognitive symptoms in AD and MCI
Apathy and depression are the most frequent non-
cognitive symptoms in MCI and AD [39–41]. Research
has shown that motivational variables can predict depres-
sion in non-demented samples. Prospective studies have
found motivational self-regulation to predict depression
[42] and self-efficacy to predict a variety of emotional
health outcomes [9]. Correlational studies have gathered
consistent support for the association of motivational vari-
ables and emotional health, e.g., mental and psycho-
somatic disorders [10, 37], in particular depression and
anxiety [11, 43, 44].
There is evidence of an association between depressive
symptoms and a higher rate of conversion form MCI to
dementia [45, 46]. However, there is evidence that
motivation-related symptoms of depression have a
higher predictive value than the affect-related symptoms
[47, 48]. Therefore, it is not surprising that apathy is also
associated with a higher rate of conversion form MCI to
dementia [39, 49].
Apathy can be a symptom of a neurodegenerative dis-
eases or a syndrome in its own right [50]. As a symptom,
it is frequently observed in various neuropsychiatric dis-
eases [51]. As a syndrome, i.e., as a group of typically
covarying symptoms, it has gained increasing interest in
the past two decades [52]. Therefore, while current psy-
chiatric classification systems do not provide a definition
of the apathy syndrome, recently proposed diagnostic cri-
teria define apathy as a loss or diminution of goal-directed
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behavior, cognition, or emotion [53]. Most current re-
search on apathy defines it as a lack of motivation relative
to the patient’s previous level of functioning or the stan-
dards of his/her age and culture [50, 54]. Although lack of
motivation is still considered by many researchers to be
the most important component of the apathy syndrome
[52], apathy also relates to other dimensions such as inter-
est, activity, and emotion. Therefore the current diagnostic
criteria are based on the definition of apathy as lack of
goal-directed behavior, cognitive activity, and emotion
[53]. The goal-directed character of apathy corresponds to
the goal-directed quality of motivational processes out-
lined above: Self-regulatory strategies (i.e., decision, activa-
tion, and motivation regulation) are needed to effectively
implement a goal, in particular in the face of difficulties.
Apathy, similar as depression, can also be assumed to
be predicted by motivational variables. Apathy has been
linked to greater impairments in activities of daily living
and a greater degree of functional decline [55] and is a
distressing behavioral change for caregivers of patients
with AD [56].
The distinction of apathy and depression is quite well
established [57]. Although there is an overlap in symp-
toms (e.g., diminished interest, psychomotor retardation),
there are some clear differences. Depression is character-
ized by dysphoric symptoms of sadness or feelings of guilt,
while apathy is characterized by a lack of emotional re-
sponsiveness (emotional indifference) [58]. There are also
differences in the pattern of associated cognitive deficits
[59]. Additionally, neuroimaging studies have demon-
strated distinct neural pathways [60].
Goals of the present analysis
While the MoReA study includes four testing times, the
goals of the present analysis refer only to baseline and
one-year follow-up data and are as follows: to describe
the longitudinal course of the sample including diagno-
ses of MCI, AD, depression and apathy and the rate of
conversion from MCI to AD; to apply the motivational
reserve model by comparing MCI and AD; to investigate
the intercorrelations of all motivational variables (in
order to know shared and unshared variance); to investi-
gate the longitudinal course of behavioral motivation
tests (delay of gratification and delay discounting); and
to apply the motivational reserve model by predicting
depression and global cognition at follow-up.
Method
Study design
The study has a prospective longitudinal design with one
within-subjects variable (times of testing). The present
analysis includes the baseline and one-year follow-up (FU)
data. At baseline, the physical/neurological examinations,
standard clinical assessment, neuropsychological testing,
and assessment of motivational variables were performed.
At FU, neuropsychological testing including cognition,
functional abilities, behavioral and affective symptoms,
and global clinical assessments of severity have been
repeated. The study protocol was first approved by the
Cantonal Ethics Committee of the canton Zurich,
Switzerland (No. E-16/2006). This approval covers the
hospitals in the canton of Zurich. The cantonal ethics
committees of the cantons Aargau, Chur, St. Gallen, and
Thurgau as well as the ethics committee of Caritas Socialis
Vienna also approved the study protocol covering the hos-
pitals in their respective area of responsibility, following
the basic approval by the ethics committee of Zurich (see
Additional file 1 for the STROBE Statement).
Sample
The MCI subjects and mild AD patients were recruited
from 14 collaborating local hospitals and clinics in the
German-speaking part of Switzerland and one institution
in Vienna, Austria, between 2009 and 2012. All the co-
operating clinics had a department that specialized in
diagnosing cognitive impairment and dementia. The
subjects were referred by their general practitioners,
community health services, or specialists in neurology,
psychiatry, or geriatrics, and clinic-based neurological
services in the greater area of Zurich, Switzerland. For
inclusion in this study, the subjects had to be diagnosed
as either MCI or AD at baseline (see diagnostic criteria
below) and of age 55 or older. The exclusion criteria
were a history of a malignant disease, severe organ fail-
ure, metabolic or hematologic disorders, neurosurgery
or neurological condition such as Parkinson’s disease,
epilepsy, postencephalitic and postconcussional syn-
drome. Written informed consent was obtained from all
the participants and caregivers prior to their inclusion.
Information on sample attrition is presented in Fig. 1.
Overall, 133 individuals who met the inclusion and ex-
clusion criteria were referred from the participating
memory clinics to the study center. Twenty-two of these
refused to participate, which resulted in 111 participants
(64 with MCI and 47 with mild AD) at baseline. At
follow-up 1, 14 (12.6 %) of the participants dropped out,
which left 97 (87.4 %) in the study (44 with MCI, 45
with mild AD, and 8 with moderate AD). The reasons
for drop-out are given in Fig. 1.
Clinical and neuropsychological assessment
Cognitive function is primarily tested with the Consor-
tium to Establish a Registry for Alzheimer’s Disease –
Neuropsychological Assessment (CERAD-NP) [61] in-
cluding the Mini Mental State Examination (MMSE) [62].
Further cognitive tests are added so there are at least two
tests per domain. All the cognitive measures are given by
all the sites. This battery includes:
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 Episodic verbal memory: CERAD Word List
Memory (learning, recall, and recognition) [63];
logical Memory subtest of the Wechsler Memory
Scale-Revised (WMS-R) [64]; Digit Span Forward
from the Wechsler Adult Intelligence Scale-III
(WAIS-III) [65];
 Episodic non-verbal memory: Visual Reproduction
subtest of the WMS-R; Figure recall score of the
CERAD Constructional Praxis [66].
 Semantic memory: CERAD Animal Naming Task
[67]; Modified Boston Naming Test (BNT) [68];
Controlled Oral Word Association Test [69];
 Visuoconstructive ability: Figure copy score of the
CERAD Constructional Praxis [66]; Picture
Completion subtest of the WAIS-III;
 Attention /cognitive speed: Trail Making Test –Part
A [70]; Digit Symbol Substitution Test from the
WAIS-III; Table 1 of the Stroop Color-Word
Test [71];
 Executive function: Task switching: Trail Making
Test –Part B [70]; Inhibition of prepotent
responses: Stroop Color-Word Test [71]; Updating
working memory: Digit Span Backward from the
WAIS-III.
Because of the wide range of cognitive function, individ-
ual cognitive tests are subject to floor and ceiling artifacts
[72]. To minimize such artifacts and other sources of
measurement error, we calculated composite measures for
the cognitive domains and a global cognition composite
score. By converting the component tests to z scores by
using the baseline mean and SD of all study participants
and averaging the z scores, the composite measures were
constructed.
Non-cognitive symptoms are assessed using the fol-
lowing measures:
 Activities of daily living (ADL) were assessed by the
Barthel Index [73], which is the standard ADL
measure in German speaking countries.
Instrumental activities of daily living (IADL) was
assessed by the Bayer-ADL [74], which is a 25-item
self- and informant-rated, internationally used
questionnaire with established validity and reliability.
 Depression and apathy were assessed by the short
form of the Geriatric Depression Scale (self- and
informant-reported) (GDS) [75], the Cornell Scale
for Depression in Dementia (clinician-rated)
(CSDD) [76], and the Apathy Evaluation Scale
(self-, informant- and clinician-rated) (AES) [77].
The diagnosis of depression was based on the
provisional diagnostic criteria for depression of
AD [78]. The diagnosis of apathy was based on
the criteria proposed by Starkstein et al. [79].
Finally, global clinical assessments of severity were
performed using the Clinical Dementia Rating (CDR)
scale [80].
Eligible persons
(n = 133)
Participants
at baseline
(n = 111)
MCI 64
Mild AD 47
Nonparticipants at baseline
(n = 22)
Refused 22
Participants
at follow-up I
(n = 97)
MCI 44
Mild AD 45
Moderate AD 8
Nonparticipants at follow-up I
(n = 14)
Deceased 3
Severely ill 2
Unreachable 1
Refused 8
Fig. 1 Flow chart describing sample size
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Diagnostic procedures
The diagnoses of probable AD were made according
to the DSM-IV-TR criteria for AD and the National
Institute of Neurological and Communicative Disor-
ders and Stroke/Alzheimer’s Disease and Related
Disorders Association (NINCDS-ADRDA) criteria for
AD [81]. The NINCDS-ADRDA criteria require a
history of cognitive decline and evidence of impair-
ment in memory and at least one other cognitive
domain. Possible AD cases (in NINCDS-ADRDA ter-
minology) were also included, i.e., persons who met
these criteria and also had another condition thought
to be contributing to cognitive impairment. Only AD
cases with a mild dementia severity were included,
and this was determined by the Clinical Dementia
Rating (CDR) scale (i.e., scores of 1) [80] and the
Mini Mental State Examination (MMSE) (i.e., scores
of 18–28) [62].
MCI was defined according to the international con-
sensus criteria [82]: (a) absence of dementia as diagnosed
by the DSM–IV criteria (MMSE ≥ 24); (b) cognitive de-
cline, i.e., according to self and/or informant report and
impairment on objective tasks and/or evidence of
decline over time on objective cognitive tasks; (c) pre-
served basic activities of daily living and not exceeding
minimal impairment in complex instrumental functions
(CDR ≤ 0.5); (d) at least mild impairment in one of the
following cognitive domains: memory, language, praxis,
executive function, and attention.
Consensus conferences across the participating sites
were held to assure that the diagnostic criteria were
applied similarly across sites.
Assessment of motivational variables
Our measurement strategy involved four different
approaches.
Table 1 Characteristics of Participants with Mild Cognitive Impairment (MCI) and Mild Alzheimer Disease (AD) at Baseline
Characteristic Baseline FU
Totala (n = 111) MCI (n = 64)a Mild AD (n = 47)a pb Totala (n = 97) pb
Age, years 75.3 (8.1) 73.2 (7.4) 78.0 (8.3) .002** 76.2 (8.5) .000***
Sex, % Female 53.2 43.8 66.0 .021*
Education, years 12.0 (2.7) 12.3 (2.5) 11.7 (3.0) .224
Activities of Daily Living (Barthel) 95.7 (11.9) 99.1 (4.1) 91.0 (16.9) .000*** 95.0 (12.5) .261
Instrumental ADL Self-report (Bayer-ADL) 2.7 (1.5) 2.4 (1.1) 3.1 (1.8) .027* 2.7 (1.8) .345
Instrumental ADL Informant-report (Bayer-ADL) 3.7 (2.3) 2.5 (1.5) 5.2 (2.2) .000*** 4.0 (2.4) .002**
Cognitive status (MMSE) 25.3 (3.3) 27.1 (2.0) 22.9 (3.0) .000*** 24.9 (3.8) .037*
Verbal Intelligence (WST) 30.6 (6.2) 31.9 (6.0) 28.7 (6.1) .006**
Episodic Verbal Memoryc −0.001 (.75) 0.42 (.61) −0.58 (.51) .000*** -.09 (.8) .000***
Episodic Nonverbal Memoryc −0.007 (.86) 0.43 (.77) −0.60 (.60) .000*** .01 (.9) .442
Semantic Memoryc 0.005 (.82) 0.35 (.58) −0.47 (.85) .000*** -.23 (.9) .000***
Visuoconstructive abilityc −0.01 (.89) 0.38 (.65) −0.55 (.89) .000*** −.04 (.9) .409
Attention/cognitive speedc 0.0001 (.77) 0.28 (.66) −0.38 (.75) .000*** −.16 (1.1) .033*
Executive Functionc −0.03 (.71) 0.28 (.66) −0.44 (.55) .000*** −.19 (1.1) .065
Global Cognitionc −0.005 (.62) 0.36 (.45) −0.51 (.43) .000*** −.11 (.8) .000***
Depression Self-report (GDS) 3.3 (2.6) 3.1 (2.7) 3.6 (2.5) .412 2.9 (2.6) .513
Depression Informant-report (GDS) 4.3 (3.4) 3.6 (3.3) 5.2 (3.4) .013* 3.5 (2.9) .283
Depression Clinical Rating (CSDD) 3.0 (3.9) 2.9 (3.4) 3.1 (4.5) .904 3.8 (3.9) .112
Apathy Self-report (AES) 31.5 (6.6) 30.8 (7.2) 32.5 (5.6) .186 31.0 (6.9) .273
Apathy Informant-report (AES) 37.2 (11.3) 35.7 (11.7) 39.3 (10.5) .101 38.0 (11.7) .138
Apathy Clinical Rating (AES) 35.0 (7.5) 33.7 (7.9) 36.9 (6.6) .027* 34.6 (8.8) .292
Neuropsychiatric Inventory Total 6.8 (10.7) 6.3 (9.7) 7.5 (11.9) .561 6.9 (9.5) .910
Activities (self-report) 32.3 (10.3) 34.1 (9.7) 29.7 (10.7) .027* 32.9 (11.5) .980
Perceived Social Support 4.2 (.54) 4.1 (0.6) 4.2 (0.5) .445 4.2 (.6) .617
Abbreviations: MMSE Mini-Mental State Examination, WST Wortschatztest (Vocabulary Test), GDS Geriatric Depression Scale, CSDD Cornell Scale for Depression in
Dementia, AES Apathy Evaluation Scale
aUnless otherwise specified, the data represent the mean (SD)
bP value of t or χ2 tests. *p < .05, **p < .01, ***p < .001
cAverage of z scores. See Methods section for included tests
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1) Midlife motivation-related occupational score. The
basis of this retrospective estimation of MR is the
main occupation of the subject and a sample of
Occupational Information Network (O*NET)
variables [15]. The O*NET is the official occupational
classification system of the US Department of labor
[83, 84]. Beside a hierarchically structured lexicon of
occupations, the O*NET includes a large database of
work and worker characteristics associated with each
occupation. This database is the result of a continuing,
large-scale research program over recent decades. In
the O*NET data collection program, samples of
workers in each occupation were assessed using
questionnaires including items on work and
worker characteristics. For the goal orientation
variable, for example, workers were asked “How
important is organizing, planning, and prioritizing
work (i.e., developing specific goals and plans to
prioritize, organize, and accomplish your work) to
the performance of your current job?” Answers
were coded on a 5-point scale.
The procedure of estimating former motivational abil-
ities consists of three steps. First, the subjects and their
informants were asked to name the occupations they
held (a) in their first job after finishing their education
that was held for at least 1 year, (b) in their (maximum
of four) longest held jobs, and (c) in the last job of their
professional life. For each job, information was collected
on the start and finish dates, job title, and major activ-
ities and duties. Second, O*NET occupational codes
corresponding to the main occupation were assigned to
each participant. Information on the subjects’ major
occupational activities and duties was crucial for their
coding to O*NET occupations. The coders compared
the activities and duties the participants reported with
those provided in the O*NET classification system. The
occupation that exhibited the best match was selected.
Therefore, this coding procedure is also largely applic-
able to Swiss occupations. Each participant’s occupa-
tional information was coded independently by two
coders. When a disagreement between the coders was
found, the participant’s answers and the O*NET job de-
scriptions were reexamined and the coding alternatives
was discussed until a consensus was reached. The sub-
jects who had been housewives for the longest period of
their life were classified according to their second-
longest held job. Third, the value of two O*NET
variables that comprises motivational processes (“goal
orientation” and “action planning”) were assigned to the
participants. These two variables have been selected in a
previous study, see [15] for more information. A com-
posite measure was calculated after converting the two
O*NET variables to z scores by using the baseline mean
and SD of all the study participants and averaging the
z scores.
2) Behavioral tasks: Delay of Gratification and Delay
discounting. Delay of gratification (DoG) tasks have
been used extensively to measure motivational
self-regulation in children [85]. We developed a
DoG for Adults (DoG-A) task [86] that used four
rewards: snacks (8 items), hypothetical money (8
items), real money (1 item), and magazines (1
item). A total score was calculated from all items.
The framing story was that the participant and
interviewer draw a pawn on a board through the
streets of a city. On each field, a card was drawn that
asks the participant for a decision. The participant
was informed that his preferences and interests are
being assessed. In the previous session, various sweets
and snacks of small size had been offered, and the
participant was asked to choose his two favorites. The
same was done to find their favorite magazine.
These are simple decisions that individuals with MCI
and mild AD are capable of making. Ten percent of the
participants in our pilot study exhibited a mild cognitive
impairment but had no difficulties with the DoG-A [86].
Support for its validity comes from correlations with
delay discounting and self-reported motivation regula-
tion as well as zero correlations with cognitive tests of
verbal intelligence, memory, processing speed, verbal
fluency, and executive function [86].
The delay discounting rate was assessed using the Delay
Discounting questionnaire [87]. The participants were
presented with a fixed set of 27 choices between smaller,
immediate money rewards and larger, delayed rewards.
For example, the participants were asked “Would you
prefer CHF 68 today or CHF 69 in 92 days?” The 27 items
were grouped into three magnitude categories: small (32–
44 Swiss Francs, CHF), medium (CHF 63–76), and large
(CHF 95–107). The discounting rates were estimated on
the basis of the pattern of 27 choices. Discounting curves
have been shown to be best described by a hyperbolic
decay function. The discounting rate k increases with the
individual’s preference for immediate rewards. Therefore,
a higher discounting rate k can be interpreted as lower
self-control or higher impulsiveness. The validity of k as a
behavioral measure of self-control/impulsiveness is indi-
cated by its correlation with impulsiveness [88, 89].
3) Motivational Scenario Test (MST). The MST is a
newly developed measure of motivational processes
[Forstmeier & Maercker: The Motivational Reserve
Scenario Test (MRST), in preparation]. The scenario
technique has previously been used in research on
self-regulation [90]. Four short scenarios were
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described to the participant in either oral or written
form. In each of the scenarios, the exertion of motiv-
ational abilities was required (e.g., motivation, deci-
sion, activation regulation, and self-efficacy). The
subjects were instructed to immerse themselves in this
scenario and to imagine being in this situation. To
support the identification with the scenario, the sub-
ject was asked to state his or her thoughts and emo-
tions that appeared (these were not subjected to
analysis). Then, they were asked what they would do
in this situation. Four items with a 5-scale answer
format (1 = I would definitely not do this, 3 = neutral,
5 = I would definitely do this) had to be answered; two
of these reflected high motivational ability and two
reflected low motivational ability (inversely rated).
Scores from 4 to 20 were possible in each scenario.
Our pilot study has shown that participants with
mild cognitive impairments were able to state their
preferred reaction in these imagined situations.
Participants with mild AD were observed in the
present study to be also capable to imagine the
situations and answer the simple questions.
4) Self-report and informant-report questionnaires.
Four variables (motivation regulation, decision
regulation, activation regulation, and self-efficacy)
have been assessed from two perspectives (self-report
and informant-report) and two time points (present
and retrospective), which resulted in four versions
each. Informant-report questionnaires that estimate
the participant’s premorbid motivational abilities
during the age of 30–50 are modifications of
established self-report measures. We chose a cut off
of 30 because individuals still experience considerable
personality change in their 20’s. The items of the
informant-report versions were slightly rephrased
compared to the original questionnaires to assess the
same aspect retrospectively and from the informant’s
point of view (e.g., “I energetically pursue my
goals” - “He/she energetically pursued his/her goals.”).
Four scales were used:
Two scales of the Volitional Components Questionnaire
(VCQ) [10] were used to assess motivation regulation (e.g.,
“He/she could usually motivate his/herself quite well if his/
her determination to persevere weakened;” Cronbach’s
alpha = .87) and decision regulation (e.g., “When he/she
thought about doing or not doing something, he/she
usually arrived at a decision quickly;” alpha = .69).
We used the locomotion scale of the Locomotion and
Assessment Questionnaire (LAQ) [11] to measure acti-
vation regulation. The scale consists of 10 statements
regarding activating oneself or starting an action (e.g.,
“When he/she decided to do something, he/she couldn’t
wait to get started;” alpha = .74).
The General Self-Efficacy scale (GSE) [91] assesses
the “broad and stable sense of personal competence to
deal effectively with a variety of stressful situations” ([91],
p. 243). Participants rated 10 items (e.g., “He/she was
confident that he/she could deal efficiently with unex-
pected events”) on a 4-point scale (alpha = .91).
Whenever possible, both the informant retrospective
version and the self-report retrospective version were used
(e.g., “I energetically pursued my goals;” alphas between .66
and .84). The subjects also completed the original version,
i.e., referring to their current motivational abilities (e.g., “I
energetically pursue my goals;” alphas between .66 and .89).
Finally, the informant completed a version that refers to the
present (e.g., “He/she energetically pursues his/her goals;”
alphas between .75 and .91).
Assessment of cognitive reserve
CR is measured using an O*NET-based estimate of
premorbid cognitive abilities and the three typical in-
dices of education, verbal intelligence, and stimulating
activities [18].
1) Midlife cognition-related occupational score. We
described the O*NET in the previous section. We
selected four variables that correlated significantly
with verbal intelligence (measured with a vocabulary
test) but not with established self-report measures of
motivational abilities: selective attention, recognizing
problems, assessing performance, and social
perceptiveness [15]. The value of these O*NET
variables was assigned to the participants. A
composite measure was calculated after the four
O*NET variables were converted to z scores by
using the baseline mean and SD of all the study
participants and averaging the z scores.
2) Education. Education was measured in terms of the
highest year of schooling completed. Persons with a
university (master’s) degree were coded as having
completed 18 years of education, and persons with a
PhD or MD were coded as having completed
21 years of education regardless of their actual years
in school.
3) Verbal intelligence. Premorbid IQ was estimated
by using a verbal intelligence test. Verbal
intelligence, as measured with a German
vocabulary test (Wortschatztest, WST) [92],
remains relatively preserved in old age and in
the early stages of AD, and thus, constitutes a
good estimate for premorbid IQ [93]. The test
consists of 42 lines with six words each. One of
the words in a line is real and five are nonsense.
In each line, the participants were asked to
identify the real word. Difficulty increased from
line to line.
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4) Stimulating activities. A questionnaire that was filled
in by the patient and the informant assessed
activities, in a way similar to [36, 94]. The patients
and informants were asked to rate how often the
subjects participated in 21 common activities
during the past twelve months on a 6-point scale
(1 = every day or about every day; 2 = several
times a week; 3 = once a week; 4 = several times a
month; 5 = several times a year; 6 = never). The
eight physical activities included walking,
bicycling, swimming, muscle training, game
sports, gymnastics, dancing, and housekeeping or
gardening. The five cognitive activities included
reading books/newspapers, writing, studying,
working crossword puzzles, and playing cards or
board games. The four creative activities included
playing a music instrument, painting, cooking,
and sewing/knitting/crocheting. Finally, the four
social activities included meeting with people,
attending the theatre/concerts/exhibitions, political
engagement, and social engagement (e.g., church).
Five mean scores were be calculated: four category
scores and one total score (alpha = .65 and .66 for
the self-report and informant-report versions,
respectively).
Procedure
Individuals who fulfilled the selection criteria for the AD
or MCI group as well as their caregivers/informants
were informed about the study by the therapeutic staff
at the clinical institutions or by the researcher involved
in the study, and given a leaflet that explained the objec-
tives and procedures. The patients and informants who
expressed interest in participation provided written con-
sent to meeting with a project psychologist or receiving
a phone call from him.
The participants’ current health history was reviewed
with the patients and/or the informant at FU, and this
included neuropsychological testing and an assessment
of behavioral measures of motivational processes. Exam-
iners were blinded to previously collected data. In the
MCI group, the diagnosis of dementia was reappraised.
The first meeting had a duration of approximately
60 min, and the second meeting had a duration of ap-
proximately 90 min. If the meeting took longer than this
or the patient/informant arrived at his attention limit, a
further meeting was arranged. Parallel to the assessment
of the patient, the caregiver was interviewed and com-
pleted questionnaires.
Statistical analysis
A principal components analysis (with varimax rotation)
was performed in order to reduce the number of motiv-
ational variables in the planned analyses. Seven factors
have been extracted by visual inspection of the scree plot,
with the following variables loading mainly on these fac-
tors (see Additional file 2: Table S1): 1) motivation-related
occupational score; 2) DoG and DD; 3) motivational
scenario test; 4) the four self-report measures (presence);
5) the four self-report measures (retrospective); 6) the
four informant-report measures (presence) as well as
three informant-report retrospective measures (motivation
regulation, decision regulation, and self-efficacy); and 7)
activation regulation in its informant-report (retrospect-
ive) version. The seven factors account for 72.3 % of the
total variance. Since DD, with money as reward, is a sub-
component of the DoG measure, we decided to use only
DoG in the following analyses. Composite scores for self-
report presence, informant-report presence, and self-
report retrospective were calculated by converting the
component tests to z scores and averaging the z scores.
The three informant report retrospective variables were
not included in the composite score in order to have a
pure presence-related score. The retrospective informant-
report score includes only the activation regulation
variable.
The group (AD and MCI) differences in the demo-
graphic and clinical measures were tested by using χ2
and t-tests. Pearson product–moment (and Spearman
rank) correlations were used to test the associations
among the motivational variable measures and their re-
lation to neuropsychological performance in the AD and
MCI groups. To adjust for 21 correlation tests (Tab. 4),
the critical alpha-level was reduced to .0024. Two separ-
ate multiple hierarchical regression analyses were con-
ducted to examine the baseline predictors of global
cognition and depression at FU.
Results
Sample characteristics
Characteristics of the sample and the descriptive data
at baseline are given in Table 1. The 111 participants
(64 with MCI and 47 with mild AD at baseline) had a
mean age of 75 (age range 55–94) and a mean duration of
education of 12 years. Fifty-three percent of the partici-
pants were women. The participants with AD were signifi-
cantly older and more functionally and cognitively
impaired than those with MCI. They also tended to have
more neuropsychiatric symptoms, but this is only signifi-
cant for informant-rated depression as well as clinician-
rated apathy.
Diagnoses of MCI, AD, depression, and apathy
Table 2 presents the diagnoses of MCI and AD at base-
line and follow-up. From the 64 MCI cases at baseline,
13 (20.3 %) converted to mild AD at follow-up. From
the 47 mild AD cases at baseline, 32 (68.1 %) remained
mild AD and 8 (17.0 %) progressed to moderate AD.
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Structured clinical interviews were used to establish
the rate of depression of Alzheimer’s Disease (DAD) and
apathy at baseline and follow-up. Nine percent of the
total baseline sample received the diagnosis of DAD;
there was no difference between the MCI and AD cases
(9.4 % vs. 8.5 %, χ2 = .02, p = 1.00). Then, 20.7 % were
diagnosed with DAD at follow-up, and again there was
no difference between the MCI and AD cases (20.3 % vs.
21.3 %, χ2 = .02, p = 0.90). There was a significant differ-
ence between the test times (McNemar: p = .007).
Apathy was diagnosed in 7.2 % of the total sample at
baseline, without a difference between the MCI and AD
cases (7.8 % vs. 6.4 %, χ2 = .08, p = 0.77). Slightly more,
i.e., 14.4 % of the total sample received an apathy diag-
nosis at follow-up, with significantly more apathy in the
AD group (7.8 % vs. 23.4 %, χ2 = 5.34, p = 0.02). However,
the difference between test times was not significant
(McNemar: p = 0.13).
Motivational variables: intercorrelations and comparison
of MCI and AD
In terms of the O*NET major occupational groups, the
largest group (21 %) had worked in office and adminis-
trative support occupations, 14 % had worked in man-
agement occupations, 11 % had worked in sales and
related occupations, 10 % had worked in production oc-
cupations, and less than 5 % had worked in each of the
other occupational groups (see Table 3).
The distribution of occupational groups did not differ
for the MCI and AD groups (χ2 = 29.1, p = 0.10), but
some of the occupations that show relatively high mean
motivation-related occupational abilities are more fre-
quent in the MCI participants (e.g., management, busi-
ness/financial, architecture/engineering, and installation
occupations). The 23 occupational categories differ in
their mean motivation-related (F = 6.2, p < 0.001) and
cognition-related (F = 10.4, p < 0.001) occupational abil-
ities. There are many occupations that require either more
motivation-related abilities (e.g., business/financial, archi-
tecture/engineering¸ protective service, construction, and
installation occupations) or more cognition-related abil-
ities (e.g., community/social, arts/entertainment, health-
care, and personal care occupations).
Table 4 presents the mean, standard deviations, and
comparisons between the MCI and AD participants for
the motivational variables at baseline. Generally, the
MCI and AD participants had similar motivational cap-
acities. However, the AD cases had lower motivational
capacities as measured with the motivation-related occu-
pational score and the informant-reported (present) mo-
tivational processes composite.
As expected, there were several meaningful and sig-
nificant intercorrelations between the motivational vari-
ables, although many of them were small to medium.
The motivation-related occupational score correlated
with retrospectively self-reported motivational processes
(r = .22, p < .05), which lost its significance when adjust-
ing for multiple tests. The Motivation Scenario Test
correlated with self-reported (present) motivational pro-
cesses (r = .32, p < .0024; adjusted for multiple tests).
Self-reported motivational processes in its present and
retrospective versions correlated highly significant (r = .60,
p < .0024) as well as informant-reported motivational pro-
cesses in its present and retrospective versions (r = .35,
p < .0024). Finally, DoG correlated with delay discounting
(r = −.23, p < .05) and self-reported (present) motivation
regulation (r = .22, p < .05), however, without significance
when adjusting for multiple tests (not shown in Tab. 4).
The patterns of correlations are very similar for the sub-
samples of MCI and AD cases (see Additional file 3:
Tables S2 and S3).
Longitudinal analysis of delay of gratification (DoG) and
delay discounting (DD)
DoG was relatively stable during the one-year measure-
ment interval (means in the total sample: 2.1 and 1.9 at
baseline and follow-up, respectively; main effect Time:
F = .89, p = .39; analyses controlled for age, sex, and gen-
der). DoG tended to be lower in the AD than the MCI
cases, but this difference was not statistically significant
(main effect Diagnostic category: F = 3.38, p = .07; Time x
Diagnostic category interaction: F = .59, p = .45).
DD was also relatively stable (means in the total sam-
ple: .037 and .054 at baseline and follow-up, respectively;
main effect Time: F = .65, p = .42); however, there was a
significant interaction effect for DD (F = 6.60, p = .01):
the AD cases had a reduced self-control (higher DD)
after one year (.037 vs. .082), which was not the case for
the MCI cases (.037 vs. .036). The main effect of the
diagnostic category was not significant (F = .11, p = .74).
Table 2 Diagnoses of Mild Cognitive Impairment (MCI) and Mild Alzheimer Disease (AD) at Baseline and Follow-up
Baseline Follow up
MCI (n = 44) Mild AD (n = 45) Moderate AD (n = 8) Drop-out (n = 14)
MCI (n = 64) 44 (68.8 %) 13 (20.3 %) 0 (0 %) 7 (10.9 %)
Mild AD (n = 47) 0 (0 %) 32 (68.1 %) 8 (17.0 %) 7 (14.9 %)
Note: χ2 = 58.8, p < .001
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Table 3 Frequency of Midlife Occupational Categories (O*NET-SOC Major Groups) and Mean Motivation- and Cognition-Related
Occupational Abilities
Characteristic Total MCI AD Mot. abilit. Cog. abilit.
Management Occupations (11)a 14.4 % 18.8 % 8.5 % 0.66 (.54) 0.65 (.24)
Business and Financial Operations Occupations (13) 2.7 % 4.7 % 0 % 0.85 (.58) 0.12 (.44)
Computer and Mathematical Occupations (15) 0 % 0 % 0 % - -
Architecture and Engineering Occupations (17) 3.6 % 6.3 % 0 % 1.20 (.59) 0.64 (.72)
Life, Physical, and Social Science Occupations (19) 0 % 0 % 0 % - -
Community and Social Services Occupations (21) 2.7 % 1.6 % 4.3 % 0.27 (.74) 1.07 (.51)
Legal Occupations (23) 0 % 0 % 0 % - -
Education, Training, and Library Occupations (25) 2.7 % 0 % 6.4 % 0.79 (.09) 0.63 (.47)
Arts, Design, Entertainment, Sports, and Media Occupations (27) 3.6 % 3.1 % 4.3 % −0.15 (.37) 0.38 (.31)
Healthcare Practitioners and Technical Occupations (29) 2.7 % 3.1 % 2.1 % 0.87 (.35) 1.48 (.52)
Healthcare Support Occupations (31) 3.6 % 6.3 % 0 % −0.64 (.83) 0.10 (.70)
Protective Service Occupations (33) 1.8 % 1.6 % 2.1 % 0.63 (.79) 1.27 (.01)
Food Preparation and Serving Related Occupations (35) 4.5 % 3.1 % 6.4 % −1.22 (.96) −0.74 (.60)
Building and Grounds Cleaning and Maintenance Occupations (37) 1.8 % 1.6 % 2.1 % −0.75 (.98) −1.14 (.50)
Personal Care and Service Occupations (39) 3.6 % 3.1 % 4.3 % −1.23 (.78) 0.49 (.07)
Sales and Related Occupations (41) 10.8 % 12.5 % 8.5 % 0.05 (.58) −0.03 (.26)
Office and Administrative Support Occupations (43) 20.7 % 17.2 % 25.5 % −0.42 (.49) −0.64 (.29)
Farming, Fishing, and Forestry Occupations (45) 2.7 % 0 % 6.4 % −0.93 (.80) −0.71 (.39)
Construction and Extraction Occupations (47) 1.8 % 1.6 % 2.1 % 0.75 (1.11) −0.26 (.48)
Installation, Maintenance, and Repair Occupations (49) 1.8 % 3.1 % 0 % 0.83 (.34) 0.26 (1.11)
Production Occupations (51) 9.9 % 10.9 % 8.5 % −0.08 (.81) −0.61 (.84)
Transportation and Material Moving Occupations (53) 1.8 % 1.6 % 2.1 % 0.10 (1.12) 0.49 (1.55)
Military Specific Occupations (55) 0 % 0 % 0 % - -
χ2 or F tests and p value χ2 = 29.1, p = 0.10 F = 6.2, p < 0.001 F = 10.4, p < 0.001
Abbreviations: MCI Mild Cognitive Impairment, AD Alzheimer’s disease
aThe numbers in brackets represent the number of the O*NET-SOC major groups
Table 4 Motivational Variables: Intercorrelations and Comparison of Mild Cognitive Impairment (MCI) and Mild Alzheimer Disease
(AD) (n = 111)
Characteristic (1) (2) (3) (4) (5) (6) (7)
(1) Midlife motivation-related occupational score -.09 .00 .09 .03 .22* −.05
(2) Delay of Gratification .08 .05 .11 .11 .00
(3) Motivation Scenario Test .32** .18 .19* .08
(4) Self-reported motivational processes (presence) .24* .60** .16
(5) Informant-reported motivational processes (presence) .20* .35**
(6) Self-reported motivational processes (retrospective) .12
(7) Informant-reported motivational processes (retrospective)
Total sample: M (SD) −.002 (.88) 2.10 (1.35) 49.72 (5.77) .00 (.77) .00 (.84) .00 (.73) 52.10 (8.17)
MCI (n = 64): M (SD) .15 (.90) 2.20 (1.37) 50.16 (5.32) .04 (.69) .19 (.80) −.01 (.75) 51.99 (8.08)
AD (n = 47): M (SD) −.22 (.80) 1.96 (1.33) 49.09 (6.38) −.06 (.87) −.26 (.82) .01 (.70) 52.25 (8.38)
p (of t) .034* .35 .35 .50 .005** .87 .87
*p < .05, ** < .0024. To adjust for 21 correlation tests, the critical alpha-level is reduced to .0024
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Prediction of global cognition and depression at
follow-up
Several bivariate correlations and two multiple hierarch-
ical regression analyses were conducted to examine the
baseline predictors of global cognition (average of z-
transformed scores of tests in six cognitive domains) and
depression at follow-up (Tab. 5). The following baseline
variables correlated significantly with global cognition
at FU: age (r = −.50, p < .001); global cognition (r = .88,
p < .001); activities (r = .33, p = .001); Motivation Scenario
Test (r = .21, p = .02); and informant-reported motivational
processes (r = .34, p = .001). In a regression analysis, global
cognition at FU was predicted by education (β = .12,
p = .04), baseline global cognition (β = .91, p < .001),
depression (β = .12, p = .05), and the Motivation Scenario
Test (β = .11, p = .05).
The following baseline variables correlated significantly
with depression (CSDD) at FU: age (r = .18, p = .04);
depression (r = .35, p < .001); perceived social support
(r = −.24, p = .01); instrumental ADLs (r = .35, p < .001);
delay of gratification (r = −.16, p = .05); self-reported mo-
tivational abilities (r = −.34, p < .001); and informant-
reported motivational processes (r = −.43, p < .001). In a
regression analysis, depression at FU was predicted by
only two motivational variables, i.e., self-reported motiv-
ational processes (β = −.24, p = .03) and informant-
reported motivational processes (β = −.25, p = .02).
Discussion
The current study’s main focus lies on the prediction of
disorder- and age-related cognitive impairment with mo-
tivational processes by applying our model of motiv-
ational reserve capacity [15] in a longitudinal study.
Prevalence of MCI, AD, depression, and apathy
Previous epidemiological studies found annual conver-
sion rates from MCI to AD to be between 2.3 and
19.1 % [95]. Thus, the conversion rate of 20.3 % lies at
the upper border of this interval. This somewhat higher
conversion rate compared to other studies might be
foremost attributed to the fact that a certain time period
passed between the diagnosis of MCI and the inclusion
in the study, which resulted in more than one year be-
tween the diagnosis of MCI and the follow-up.
Table 5 Summary of Bivariate Correlations and Separate Multiple Hierarchical Regression Analyses Predicting Depression and Global
Cognition at Follow-up (N = 97)
Global cognitiona at FU Depression at FU
r β p r β p
Epidemiological variables
Age −.50*** .06 .34 .18* .15 .18
Sex (1 = male, 2 = female) −.04 −.03 .67 −.08 .05 .68
Education (years) .03 −.12 .04* .08 .08 .46
Cognition-related occupational score .15 −.02 .74 −.01 .03 .84
Clinical/cognitive variables at baseline
Global cognition .88*** .91 <.001*** −.14 .05 .70
Depression .13 .12 .05* .35*** .15 .20
Activities (self-report) .33*** .04 .53 −.12 −.01 .91
Perceived Social support .06 −.02 .67 −.24** −.16 .11
Instrumental ADLs −.09 .06 .37 .35*** .23 .07
Motivational variables at baseline
Motivation-related occupational score .09 −.04 .55 .06 .08 .56
Delay of Gratification .14 −.03 .52 −.16* −.05 .59
Motivation Scenario Test .21* .11 .05* −.12 .19 .08
Self-reported motivational processes −.03 −.06 .33 −.34*** −.24 .03*
Informant-reported motivational processes .34*** .05 .38 −.43*** −.25 .02*
Corrected R2 .78 .26
F and p 24.53 <.001 3.36 <.001
Note: FU Follow-up after one year
*p < .05
**p < .01
***p < .001
aGlobal cognition: composite measures for all tests in all cognitive domains (through converting the component tests to z scores by using the baseline mean and
SD of all study participants and averaging the z scores
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Structured clinical interviews were used to establish
the rate of depression of Alzheimer’s disease and apathy
at baseline and follow-up. The diagnosis of depression
was based on the provisional diagnostic criteria for de-
pression of AD [78]. We found a prevalence of 9 at base-
line and almost 21 % at follow-up; the patients with
MCI and AD did not differ in their depression rate. The
rate at follow-up is similar to that found previously in a
sample of patients with probable AD (27.4 %) [96]. In
other studies, higher rates of depression in AD were
found, namely between 44 and 53.5 % [97–99]. The
higher rates in these studies might be attributed to the
fact that these samples had been intentionally selected
to increase the frequency of depression, as noted by
[97]. The depression rate at baseline is relatively low
(9 %) and increased to 21 % during one year. This indi-
cates that depression changes as the disease progresses.
Previous research has shown that depression typically
appears in mild to moderate stages and becomes less
prevalent in more severe stages [100]. Thus, we would
expect an inverted U-curve when looking at the develop-
ment from MCI to severe dementia.
The rate of apathy measured by a structured clinical
interview [79] was 7.8 and 7.8 % in the MCI patients
and 6.4 and 23.4 % in mild AD patients at baseline and
follow-up, respectively. This is in accordance with the
previously found 19 % in a sample of patients with prob-
able AD [79]. Higher prevalence rates can be found
when rating instruments and cut-off scores are used
[101]. This can also be demonstrated in the present
study: While the rate of apathy as diagnosed with a
structured clinical interview was 7.2 % in the total sam-
ple, it was 9.9 %, 43.1, and 30.9 % using the apathy
evaluation scale (self, informant, and clinical report,
respectively) using recommended cut-off scores [77]. In
addition, the prevalence increases with the severity of
dementia [102]. This increase in prevalence can particu-
larly be observed in patients diagnosed with mild AD at
baseline in this study, but apathy is relatively stable in
the MCI patients.
Testing of motivational reserve predictions
Individuals with MCI and AD do not differ with regards
to delay of gratification, scenario test, and self-report
measures. However, there are two interesting differences,
which support our MR model predictions. The AD cases
have lower values than the MCI cases in the midlife
motivation-related occupational score. This means that
the MCI cases had occupations that required more
motivation-related occupational abilities (e.g., manage-
ment, business/financial, architecture/engineering, and
installation occupations) more often than did the AD
cases. The same advantage of MCI cases over AD cases
with regard to the occupation-based motivational
variable was also observed in two other samples in
Germany [24] and the United States [103].
In addition, the AD cases have a lower informant-
reported (present) motivation processes score than the
MCI cases. In contrast, the AD cases rated themselves
to be not less self-regulated than the MCI cases. In other
words, only the caregivers of the AD patients and not
the patients themselves rate the patient’s motivational
abilities to be lower than the caregivers of the MCI
patients. The sources of this difference might be twofold
[104]. First, the motivational abilities of the AD cases
might be truly lower than those of the MCI cases, and
the caregivers observe this decline but the patients
themselves do not observe it because of a reduced dis-
ease awareness (“anosognosia”), which results in similar
self-report values [105]. Second, the AD cases might be
more burdened and depressed by the larger impairment of
AD vs. MCI cases and see the abilities of the patient more
negatively than they are (“caregiver rating bias”) [106].
Both processes can act together. A consequence of these
considerations is that not only should self-reports of the
patient’s symptoms and abilities be interpreted with cau-
tion but also informant-reports.
Behavioral tests such as the delay of gratification and
the delay discounting test gain a greater importance in
this sample because of the reduced validity of the self-
and informant-reports. In our sample, the people with
MCI and mild AD do not differ with regard to these
variables. The question arises how long DoG and DD re-
main stable when the disease progresses. We discuss this
topic below.
As expected, there are a multitude of meaningful and
significant intercorrelations between the MR variables
(in the whole sample and both subsamples) that are in
line with previous publications that use non-impaired
samples. Midlife motivation-related occupational abilities
correlate with retrospectively self-reported motivational
processes. This was also found in a sample of cognitively
healthy individuals [15]. Delay of gratification correlated
with delay discounting and self-reported (present) mo-
tivation regulation. This correlation pattern was also
found in a sample of cognitively healthy individuals [86],
which resulted in the interpretation that DoG represents
a behavioral test of self-motivation.
Behavioral motivational tests in longitudinal course
DoG and DD represent behavioral tests of self-control.
High self-control is reflected in high DoG and low DD.
Compared with identical test procedures for cognitively
healthy older people who exhibit an average DoG score
of 2.4 and an average DD score of 0.027 [86], self-
control in persons with MCI or mild AD seems to be
slightly lower.
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The present data give a first answer to the question of
how stable DoG and DD are during one year in the
course of disease-related cognitive impairment. Both
DoG and DD are relatively stable during the one-year
measurement interval as the non-significant main effect
Time reveals. However, there is a significant interaction
effect for DD (but not DoG): the AD cases have a re-
duced self-control (i.e., higher DD) after one year, but
this is not the case for the MCI cases.
The fact that DoG is relatively stable during one year
but cognitive functions declined significantly requires an
explanation. This result is not surprising if DoG is con-
sidered a motivational function that is different from
cognitive functions [108, 109]. However, it is surprising
if it is considered a rather cognitive, i.e., cold executive
function [109]. It has long been shown that executive
functions decline as early as the mild stages of AD [110]
and decline during the course of AD [112]. If DoG is a
cold executive function, i.e., cognitive at its core, we
would expect it to decline over a year’s time. In contrast,
motivational-affective functioning declines more slowly
during the course of Alzheimer’s dementia and is rather
preserved in its early stage [112, 113]. The present
results suggest that DoG includes motivational rather
than cognitive processes. This is also supported by the
correlation with self-reported motivation processes,
which has also been shown in a sample of cognitively
healthy older people [86].
In contrast, delay discounting was higher (i.e., self-
control was lower) after one year in the sample of pa-
tients with AD. Delay discounting includes hypothetical
money rewards that require more cognitive resources
(e.g., working memory and mathematical operations)
than the real rewards in DoG. Therefore, one can argue
that delay discounting captures cold executive functions,
while DoG covers hot executive functions.
Motivation predicting subsequent cognitive status
The research question was whether motivational vari-
ables are negatively associated with cognitive decline
and impairment. Our results provide further evidence
that this is the case. To our knowledge, this is the first
study to show motivational variables as predictors in the
course of cognitive impairment. In addition to age, base-
line cognition, and activities, two motivational variables
(the Motivation Scenario Test and informant-reported
motivational processes) correlated with global cognition
at follow-up, of which only the scenario test remained a
significant predictor in the regression analysis. In con-
trast to our previous findings, the occupation-based
measure of midlife motivational abilities was not associ-
ated with global cognition at follow-up. In a sample of
cognitively healthy individuals, the same measure was
associated with cognitive function [15]. In addition, this
measure was associated with a reduced risk of MCI and
a reduced risk of AD in ApoE ɛ4 carriers in a longitu-
dinal study [24]. Future analyses of this longitudinal
studywill reveal whether the midlife motivation-related
occupational score will predict cognitive decline over the
course of several years rather than cognitive status one
year after baseline.
Two other studies support the evidence that motiv-
ational variables are associated with cognitive decline.
Conscientiousness, which is a related construct that can
be defined as the tendency to control impulses and to be
goal directed, has been found to be associated with a
lower risk of MCI and AD in a prospective study [25]. A
high level of conscientiousness was associated with an
89 % reduction in the risk of AD. In addition, high pur-
pose in life, which results in intentionality and motivated
action, was also associated with a reduced incidence of
MCI and AD in a prospective study [26]. Although con-
scientiousness and purpose in life are not core motiv-
ational variables, they may translate into an increased
sense of intentionality or goal-directed striving and, thus,
support the findings of the present study that better mo-
tivational abilities at baseline are associated with better
cognitive function at follow-up.
Motivation predicting subsequent depression
We expected the motivational variables to be negatively
associated with depression, when controlling for other
potential predictors. Our results extend the previously
found association between motivational variables and
emotional health in a sample of cognitively impaired
individuals. In fact, two motivational variables remain
the only predictors of depression at follow-up in a
regression analysis. Age, baseline depression, perceived
social support, and instrumental ADLs showed signifi-
cant bivariate correlations but lost their significance in
the regression analysis.
Most research on the association between motivational
processes and emotional health was done with cognitive
healthy samples. For instance, prospective studies demon-
strated that motivational self-regulation predicts depres-
sion [42] and self-efficacy predicts emotional health [9].
Correlational studies support the association of motiv-
ational processes and emotional health, e.g., psychiatric
and psychosomatic disorders [10, 37, 114], in particular
anxiety and depression [11, 27].
Although there is support for the association between
motivational variables and future depression, motiv-
ational variables have rarely been included in epidemio-
logic studies on predictors of depression in the general
older population or in cognitively impaired older people.
The established risk factors of depression in non-
demented older people are bereavement, sleep disturb-
ance, disability, prior depression, and female gender, as
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demonstrated by a meta-analysis [115]. In a sample of
non-demented individuals, of whom 25 % exhibited
MCI, only functional impairment, MCI, and smoking
were significant predictors in a fully adjusted analysis
[116]. Some of these predictors were also found in our
study. Functional impairment was associated with
depression in the univariate analysis but missed signifi-
cance in the multivariate analysis. Baseline depression
was associated in only the univariate analysis. Because
baseline depression and motivational variables were
strongly associated with each other, only motivational
variables survived the regression analysis. Future epide-
miologic studies should include motivational variables as
predictors of depression in the general population and in
demented populations.
Strengths and limitations
The current study tries to extend previous research on
brain reserve or cognitive reserve in predicting age- and
dementia-related cognitive decline by introducing a
broad range of motivational variables. Cognitive and mo-
tivational status was assessed by behavioral or perform-
ance measures and informant ratings as well as standard
self-report ratings. The study predictions were based on
a theoretical model [15] that has gained some support in
methodologically diverse studies [24, 86, 103].
The results should be interpreted in light of several
limitations. The analyses were performed with only two
of the four planned assessment times of this longitudinal
study. Data of the third and fourth assessment time are
not available yet. Thus, only a brief period during the
course of a cognitive impairment is covered. In particu-
lar, the longitudinal analysis of delay of gratification and
delay discounting as well as the prediction of cognition
and depression will gain importance when a longer time
period is covered. It can assumed that delay of gratifica-
tion, which is relatively stable after one year, will eventu-
ally decrease with cognitive decline but will do so
slower.
The sample is rather small compared to many other
large-scale longitudinal studies. However, this is the first
study that focuses on motivational variables as predic-
tors of cognitive decline and emotional health in the
cognitively impaired, and we hope this will pioneer
other, larger studies on this topic.
The correlations between the motivational variables
vary between small-to-medium and large effects. Large
correlations (i.e., around .5) were found only between
the instruments that used the same procedure (e.g., self-
report) and the same source (e.g., regarding self and
present). The low-to-medium correlations may be attrib-
utable to behavioral and self-report measures that
capture different facets of a related construct, namely
motivational self-regulation. This phenomenon is also
found in other areas of psychological measurement; for
example, implicit and explicit measures of motives are
relatively independent [117]. Furthermore, self-report
measures are more prone to cognitive decline and a
social desirability response bias. Because behavioral and
self-report measures of motivation tap different aspects
of the same construct to a certain extent, it is important
to use both approaches in research to ensure the com-
prehensive assessment of the construct.
We used the current criteria of depression in AD [78]
and apathy [53] with adequate structured clinical inter-
views [79]. However, these DSM-like criteria do not have
a long tradition in Alzheimer’s and aging research and,
thus, have yet to gain a large dissemination. More re-
search will reveal the best symptom criteria for depres-
sion in AD and apathy and how changing criteria will
influence study results such as those of the present
study.
Conclusions
This research brings the episodic knowledge that the
personal abilities colloquially called will power, self-
discipline, or self-regulation protect against cognitive
decay on a scientific basis. The MoReA study aims to
investigate motivational factors that contribute to the
development of AD, including its cognitive decline as
well as depressive symptoms and apathy. Motivational
factors were neglected in previous research. Once rele-
vant motivational factors have been identified and shown
to be important in the cognitive decline of AD, new and
promising strategies for prevention and early interven-
tion can be developed and applied. Our own previous
research has shown that there are effective strategies for
enhancing motivational competencies that have been ap-
plied to various psychiatric disorders such as depression
and anxiety [37]. These strategies can be adopted for use
in prevention and psychotherapy programs at midlife,
with older people in general, or with people at risk for
AD (e.g., with MCI). Enhancing motivational abilities
might also increase the effectiveness of pharmacological
and psychosocial interventions. By targeting the neuro-
psychiatric symptoms of apathy and depression, care-
giver burden might be reduced. The results of previous
studies on brain reserve have been used to make recom-
mendations about lifestyle and activities in late life to
decrease the risk of AD [32]. The possible results of our
study would add recommendations about changes in
motivational self-regulation in later life [38].
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